107756-96-7Relevant academic research and scientific papers
Boron trifluoride-diethyl ether complex catalyzed aromatic amino-Claisen rearrangements
Anderson,Lai
, p. 1287 - 1290 (1995)
Boron trifluoride-diethyl ether complex (BF3 · OEt2) was demonstrated to be an efficient catalyst for the amino-Claisen rearrangements of various aromatic N-allylamines into the corresponding o-allylamines in moderate yields.
Nucleophilic addition of α-metallated carbamates to planar chiral cationic η3-allylmolybdenum complexes: A stereochemical study
Kocienski, Philip J.,Christopher, John A.,Bell, Richard,Otto, Bernhard
, p. 75 - 84 (2007/10/03)
Chiral α-(O-carbamoyl)alkyl- and α-(N-carbamoyl)alkylcopper(I) reagents derived from (-)-sparteine-mediated asymmetric lithiation of hindered carbamates react with cationic η3-allylmolybdenum complexes with retention of configuration.
The Acid-Catalyzed Rearrangement of 1-N-Allylindolines
Izumi, Taeko,Kasahara, Akira
, p. 1173 - 1175 (2007/10/02)
Zinc chloride-catalyzed rearrangement of 1-N-allylindoline and 1-N-(2-methylallyl)indoline proceeds readily in refluxing xylene to give 7-allylindoline and 7-(2-methylallyl)indoline in 73percent and 86percent yields, respectively.The reaction of 1-N-2-butenylindoline and zinc chloride give rise to the mixture of 7-(1-methallyl)indoline, 7-(cis- and trans-1-methyl-1-propenyl)indoline, and 7-(trans-2-butenyl)indoline.On the other hand, the similar reaction of 1-N-(3-methyl-2-butenyl)indoline with zinc chloride led to the formation of a mixture of 1,2,5,6-tetrahydro-4,4-dimethyl-4H-pyrroloquinoline and 7-(3-methyl-2-butenyl)indoline.
ADRENERGIC AMIDINES
-
, (2008/06/13)
Disclosed herein are adrenergic compounds represented by the formula STR1 wherein m is 0, 1 or 2; R 1, R 2, R 3 and R. sub.7 are taken from the group consisting of hydrogen, hydroxy, loweralkyl, loweralkoxy, halo, amino, acetamido or NHSO 2 R wherein R is taken from the group consisting of hydrogen or loweralkyl, provided that R 1, R 2, R. sub.3 and R 7 cannot simultaneously be hydrogen or halo, and provided that when one of R 1, R 2, R 3 and R 7 is halo, the others cannot simultaneously be hydrogen and when two of R 1, R 2, R 3 and R 7 are halo, the other two cannot simultaneously be hydrogen and provided that R 1 and R 7 cannot simultaneously be methoxy each when R. sub.2 and R 3 are hydrogen; R. sub.1 and R 2 or R 2 and R 3 or R 3 and R. sub.7 taken together can form a methylenedioxy or ethylenedioxy bridge; or R 1 and R 2 or R 2 and R 3 or R 3 and R. sub.7 taken together with the aromatic ring can form a benzimidazole or indole bridge; and R. sub.4 and R 5 are hydrogen or taken together form a closed ring of the formula STR2 wherein n is 1 or 2, and the combined solid and dashed line represents a single or double bond when n is 1, and R 6 is taken from the group consisting of hydrogen or loweralkyl, and the pharmaceutically acceptable salts thereof.
